Obsidian’s $160.5 Million Series C Financing Round

Leila Ahmed
Tagged:

Wilson Sonsini Goodrich & Rosati advised investor Novo Holdings on the transaction.Obsidian Therapeutics, Inc. (Obsidian), a clinical-stage biotechnology company, announced it closed an oversubscribed $160.5 million…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now